Jump to content

Fundación Jiménez Díaz
  • Quirónsalud
  • Doubts and queries
  • Site map
  • Twitter This link will open in a pop-up window.
  • Facebook This link will open in a pop-up window.
  • Youtube This link will open in a pop-up window.
  • Linkedin This link will open in a pop-up window.
  • Instagram This link will open in a pop-up window.
  • TikTok Link to external application.
  • Private appointment
  • Patient Portal Link to external application.
Language selector
Active language English
  • español
  • English
  • International version
    • Español Link to external application.
    • English Link to external application.
    • Deutsch Link to external application.
    • Pусский Link to external application.
    • العربية Link to external application.
    • Français Link to external application.
Location and transport
91 550 48 00 / 900 606 055 / Private Care: 91 090 05 16
  • Medical directory
  • Services portfolio
  • Insurance companies and mutuals
  • Our centre
    • Why choose our centre?
    • Location and transport
    • Contact information
    • Opening hours
    • Map of the centre
    • Facilities and services
    • History
    • Management structure
    • Mission, vision and values
    • Quirónsalud Group This link will open in a pop-up window.
    • Reports
    • Quality
    • Recognitions and certifications
    • Fundación Conchita Rábago
    • Programa de Alimentación Saludable
  • Actividades
  • Media section
    • News
    • Videos
    • Podcast
    • Contenidos de salud
    • Calendar of events
    • Photo and multimedia gallery
    • Virtual visits
    • 75th Anniversary FJD
  • Work with us This link will open in a pop-up window.
  • Patients and visitors
  • Research
  • Teaching
Teléfono de atención al usuario900 301 013
  • Home
  •   |   Services portfolio
  •   |   Haematology and Haemotherapy
  •   |   Ensayos clínicos
  •   |   Mieloma Múltiple
  •   |   Estudio de fase 3, aleatorizado, para evaluar la eficacia y la seguridad de la perifosina añadida a la combinación de bortezomib y dexametasona en pacientes con mieloma múltiple tratados previamente con botezomib

Haematology and Haemotherapy

Situation: Entrance Plaza Cristo Rey. Outpatient Consultations, Floor 1, Lifts 2 and 3. Hospitalisation, Unit 36, Floor 6, Lift 1 Blood Bank and Blood Donation, Ground Floor (after the Blood Draw Room).
Phone: 915504800
E-mail: hematologia.fjd@fjd.es
Head of department: Dra. Maria Pilar Llamas Sillero
Opening times: Monday 10 a.m. to 8:30 p.m. Tuesday. Wednesday. Thursday. Friday: 10 a.m. to 8.30 p.m. until further notice: Public holidays. No blood donation at weekends or at Quintana Specialist Centre.
Description
  • Equipo Médico
  • Facilities, Techniques and Procedures
  • Information for Patients
  • Subspecialities and Units
  • Research and teaching
  • Recognitions and Accreditations
Estudio de fase 3, aleatorizado, para evaluar la eficacia y la seguridad de la perifosina añadida a la combinación de bortezomib y dexametasona en pacientes con mieloma múltiple tratados previamente con botezomib
Services portfolio
  • Nuestros blogs
  • Tu canal de salud - Noticias y consejos de salud
  • Programa de Seguimiento del Embarazo
  • Portal del paciente
banner quironsalud gris
Location and transport

Hospital Universitario Fundación Jiménez Díaz

Avda. Reyes Católicos, 2
28040 Madrid Madrid

91 550 48 00 / 900 606 055 / Private Care: 91 090 05 16
  • Contact
  • Map of web
  • Disclaimer
  • Data protection
  • Cookies policy
  • Accessibility
Joint Commission International
  • Twitter This link will open in a pop-up window.
  • Facebook This link will open in a pop-up window.
  • Youtube This link will open in a pop-up window.
  • Linkedin This link will open in a pop-up window.
  • Instagram This link will open in a pop-up window.
  • TikTok Link to external application.

© 2025 Quirónsalud - All rights reserved